nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2C19—prostate cancer	0.156	0.611	CbGaD
Primidone—CYP3A4—prostate cancer	0.0992	0.389	CbGaD
Primidone—CYP2C8—Nilutamide—prostate cancer	0.0314	0.0621	CbGbCtD
Primidone—CYP2C19—Bicalutamide—prostate cancer	0.0264	0.0521	CbGbCtD
Primidone—CYP2C19—Nilutamide—prostate cancer	0.0264	0.0521	CbGbCtD
Primidone—CYP2C8—Abiraterone—prostate cancer	0.026	0.0514	CbGbCtD
Primidone—CYP2B6—Estrone—prostate cancer	0.0249	0.0491	CbGbCtD
Primidone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0243	0.0479	CbGbCtD
Primidone—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0222	0.0438	CbGbCtD
Primidone—CYP2C9—Bicalutamide—prostate cancer	0.0219	0.0433	CbGbCtD
Primidone—CYP2C9—Nilutamide—prostate cancer	0.0219	0.0433	CbGbCtD
Primidone—CYP2C19—Flutamide—prostate cancer	0.0218	0.0432	CbGbCtD
Primidone—CYP1A2—Flutamide—prostate cancer	0.0202	0.0398	CbGbCtD
Primidone—CYP2C8—Cabazitaxel—prostate cancer	0.0193	0.0381	CbGbCtD
Primidone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0168	0.0331	CbGbCtD
Primidone—CYP1A2—Estrone—prostate cancer	0.0146	0.0288	CbGbCtD
Primidone—CYP2C9—Estrone—prostate cancer	0.0131	0.0259	CbGbCtD
Primidone—CYP3A4—Bicalutamide—prostate cancer	0.0127	0.0252	CbGbCtD
Primidone—CYP3A4—Estramustine—prostate cancer	0.0118	0.0234	CbGbCtD
Primidone—CYP2C8—Estradiol—prostate cancer	0.0108	0.0214	CbGbCtD
Primidone—CYP3A4—Flutamide—prostate cancer	0.0106	0.0209	CbGbCtD
Primidone—CYP3A4—Abiraterone—prostate cancer	0.0106	0.0209	CbGbCtD
Primidone—CYP2C9—Capecitabine—prostate cancer	0.00995	0.0197	CbGbCtD
Primidone—CYP1A2—Conjugated Estrogens—prostate cancer	0.00953	0.0188	CbGbCtD
Primidone—CYP2C19—Estradiol—prostate cancer	0.00907	0.0179	CbGbCtD
Primidone—CYP1A2—Estradiol—prostate cancer	0.00837	0.0165	CbGbCtD
Primidone—CYP3A4—Cabazitaxel—prostate cancer	0.00781	0.0154	CbGbCtD
Primidone—CYP2C19—Prednisone—prostate cancer	0.0078	0.0154	CbGbCtD
Primidone—CYP3A4—Estrone—prostate cancer	0.00763	0.0151	CbGbCtD
Primidone—CYP2C9—Estradiol—prostate cancer	0.00754	0.0149	CbGbCtD
Primidone—CYP2C8—Etoposide—prostate cancer	0.00706	0.0139	CbGbCtD
Primidone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0068	0.0134	CbGbCtD
Primidone—CYP2B6—Doxorubicin—prostate cancer	0.00636	0.0126	CbGbCtD
Primidone—CYP1A2—Etoposide—prostate cancer	0.00546	0.0108	CbGbCtD
Primidone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00499	0.00987	CbGbCtD
Primidone—CYP3A4—Mitoxantrone—prostate cancer	0.00454	0.00897	CbGbCtD
Primidone—CYP3A4—Estradiol—prostate cancer	0.00438	0.00866	CbGbCtD
Primidone—CYP3A4—Prednisone—prostate cancer	0.00377	0.00745	CbGbCtD
Primidone—CYP3A4—Etoposide—prostate cancer	0.00286	0.00566	CbGbCtD
Primidone—CYP3A4—Docetaxel—prostate cancer	0.00262	0.00518	CbGbCtD
Primidone—CYP3A4—Doxorubicin—prostate cancer	0.00195	0.00386	CbGbCtD
Primidone—Methsuximide—CYP2C19—prostate cancer	0.000339	0.099	CrCbGaD
Primidone—Phenytoin—CYP2C18—prostate cancer	0.000332	0.0967	CrCbGaD
Primidone—Phensuximide—CYP2C19—prostate cancer	0.000329	0.0959	CrCbGaD
Primidone—Phenobarbital—CYP2C18—prostate cancer	0.000318	0.0927	CrCbGaD
Primidone—Blood disorder—Epirubicin—prostate cancer	0.000306	0.0025	CcSEcCtD
Primidone—Anaemia—Goserelin—prostate cancer	0.000299	0.00245	CcSEcCtD
Primidone—Vomiting—Degarelix—prostate cancer	0.000299	0.00245	CcSEcCtD
Primidone—Rash—Degarelix—prostate cancer	0.000297	0.00243	CcSEcCtD
Primidone—Dermatitis—Degarelix—prostate cancer	0.000296	0.00243	CcSEcCtD
Primidone—Headache—Degarelix—prostate cancer	0.000295	0.00241	CcSEcCtD
Primidone—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000294	0.00241	CcSEcCtD
Primidone—Dizziness—Cabazitaxel—prostate cancer	0.000293	0.0024	CcSEcCtD
Primidone—Connective tissue disorder—Estradiol—prostate cancer	0.00029	0.00238	CcSEcCtD
Primidone—Visual disturbance—Docetaxel—prostate cancer	0.00029	0.00238	CcSEcCtD
Primidone—Vertigo—Conjugated Estrogens—prostate cancer	0.000288	0.00236	CcSEcCtD
Primidone—Agranulocytosis—Mitoxantrone—prostate cancer	0.000286	0.00234	CcSEcCtD
Primidone—Visual impairment—Estradiol—prostate cancer	0.000284	0.00233	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—prostate cancer	0.000283	0.00232	CcSEcCtD
Primidone—Vomiting—Cabazitaxel—prostate cancer	0.000282	0.00231	CcSEcCtD
Primidone—Nausea—Degarelix—prostate cancer	0.000279	0.00229	CcSEcCtD
Primidone—Headache—Cabazitaxel—prostate cancer	0.000278	0.00227	CcSEcCtD
Primidone—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000277	0.00227	CcSEcCtD
Primidone—Fatigue—Ethinyl Estradiol—prostate cancer	0.000277	0.00227	CcSEcCtD
Primidone—Arthralgia—Goserelin—prostate cancer	0.000276	0.00226	CcSEcCtD
Primidone—Eye disorder—Estradiol—prostate cancer	0.000276	0.00226	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000274	0.00224	CcSEcCtD
Primidone—Arthralgia—Conjugated Estrogens—prostate cancer	0.000273	0.00224	CcSEcCtD
Primidone—Asthenia—Bicalutamide—prostate cancer	0.000273	0.00224	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000271	0.00222	CcSEcCtD
Primidone—Diplopia—Capecitabine—prostate cancer	0.000266	0.00218	CcSEcCtD
Primidone—Nausea—Cabazitaxel—prostate cancer	0.000263	0.00216	CcSEcCtD
Primidone—Phenobarbital—CYP1B1—prostate cancer	0.000263	0.0767	CrCbGaD
Primidone—Nervous system disorder—Goserelin—prostate cancer	0.000259	0.00213	CcSEcCtD
Primidone—Mental disorder—Estradiol—prostate cancer	0.000258	0.00212	CcSEcCtD
Primidone—Ataxia—Docetaxel—prostate cancer	0.000258	0.00212	CcSEcCtD
Primidone—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000257	0.00211	CcSEcCtD
Primidone—Malnutrition—Estradiol—prostate cancer	0.000257	0.0021	CcSEcCtD
Primidone—Skin disorder—Goserelin—prostate cancer	0.000257	0.0021	CcSEcCtD
Primidone—Skin disorder—Conjugated Estrogens—prostate cancer	0.000254	0.00208	CcSEcCtD
Primidone—Anorexia—Goserelin—prostate cancer	0.000252	0.00207	CcSEcCtD
Primidone—Dizziness—Bicalutamide—prostate cancer	0.000251	0.00206	CcSEcCtD
Primidone—Ataxia—Capecitabine—prostate cancer	0.00025	0.00205	CcSEcCtD
Primidone—Anorexia—Conjugated Estrogens—prostate cancer	0.00025	0.00205	CcSEcCtD
Primidone—Ethotoin—CYP2C19—prostate cancer	0.000244	0.071	CrCbGaD
Primidone—Vomiting—Bicalutamide—prostate cancer	0.000242	0.00198	CcSEcCtD
Primidone—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000241	0.00197	CcSEcCtD
Primidone—Rash—Bicalutamide—prostate cancer	0.00024	0.00196	CcSEcCtD
Primidone—Dermatitis—Bicalutamide—prostate cancer	0.000239	0.00196	CcSEcCtD
Primidone—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000239	0.00196	CcSEcCtD
Primidone—Headache—Bicalutamide—prostate cancer	0.000238	0.00195	CcSEcCtD
Primidone—CYP2C19—urine—prostate cancer	0.000238	0.155	CbGeAlD
Primidone—Agranulocytosis—Etoposide—prostate cancer	0.000238	0.00195	CcSEcCtD
Primidone—Somnolence—Goserelin—prostate cancer	0.000235	0.00193	CcSEcCtD
Primidone—Somnolence—Conjugated Estrogens—prostate cancer	0.000233	0.00191	CcSEcCtD
Primidone—Psychotic disorder—Prednisone—prostate cancer	0.000231	0.0019	CcSEcCtD
Primidone—Vertigo—Estradiol—prostate cancer	0.000231	0.00189	CcSEcCtD
Primidone—Asthenia—Ethinyl Estradiol—prostate cancer	0.00023	0.00189	CcSEcCtD
Primidone—Decreased appetite—Goserelin—prostate cancer	0.00023	0.00188	CcSEcCtD
Primidone—Fatigue—Goserelin—prostate cancer	0.000228	0.00187	CcSEcCtD
Primidone—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000228	0.00187	CcSEcCtD
Primidone—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000226	0.00185	CcSEcCtD
Primidone—Fatigue—Conjugated Estrogens—prostate cancer	0.000226	0.00185	CcSEcCtD
Primidone—Nausea—Bicalutamide—prostate cancer	0.000226	0.00185	CcSEcCtD
Primidone—Anaemia—Mitoxantrone—prostate cancer	0.000221	0.00181	CcSEcCtD
Primidone—Arthralgia—Estradiol—prostate cancer	0.000219	0.00179	CcSEcCtD
Primidone—Phenytoin—CYP3A5—prostate cancer	0.000218	0.0637	CrCbGaD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000217	0.00178	CcSEcCtD
Primidone—Eye disorder—Etoposide—prostate cancer	0.000214	0.00175	CcSEcCtD
Primidone—Dizziness—Ethinyl Estradiol—prostate cancer	0.000212	0.00174	CcSEcCtD
Primidone—Methylphenobarbital—CYP2C19—prostate cancer	0.000212	0.0618	CrCbGaD
Primidone—Phenobarbital—CYP3A5—prostate cancer	0.000209	0.0611	CrCbGaD
Primidone—Nervous system disorder—Estradiol—prostate cancer	0.000206	0.00168	CcSEcCtD
Primidone—Depression—Capecitabine—prostate cancer	0.000204	0.00167	CcSEcCtD
Primidone—Vomiting—Ethinyl Estradiol—prostate cancer	0.000204	0.00167	CcSEcCtD
Primidone—Arthralgia—Mitoxantrone—prostate cancer	0.000204	0.00167	CcSEcCtD
Primidone—Skin disorder—Estradiol—prostate cancer	0.000204	0.00167	CcSEcCtD
Primidone—Phenobarbital—CYP2A6—prostate cancer	0.000203	0.0591	CrCbGaD
Primidone—Rash—Ethinyl Estradiol—prostate cancer	0.000203	0.00166	CcSEcCtD
Primidone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000202	0.00166	CcSEcCtD
Primidone—Headache—Ethinyl Estradiol—prostate cancer	0.000201	0.00165	CcSEcCtD
Primidone—Agranulocytosis—Docetaxel—prostate cancer	0.000198	0.00162	CcSEcCtD
Primidone—CYP1A2—urine—prostate cancer	0.000194	0.126	CbGeAlD
Primidone—Agranulocytosis—Capecitabine—prostate cancer	0.000191	0.00157	CcSEcCtD
Primidone—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000191	0.00157	CcSEcCtD
Primidone—Nausea—Ethinyl Estradiol—prostate cancer	0.000191	0.00156	CcSEcCtD
Primidone—Asthenia—Goserelin—prostate cancer	0.00019	0.00155	CcSEcCtD
Primidone—Skin disorder—Mitoxantrone—prostate cancer	0.00019	0.00155	CcSEcCtD
Primidone—Asthenia—Conjugated Estrogens—prostate cancer	0.000188	0.00154	CcSEcCtD
Primidone—Connective tissue disorder—Docetaxel—prostate cancer	0.000187	0.00153	CcSEcCtD
Primidone—Somnolence—Estradiol—prostate cancer	0.000186	0.00153	CcSEcCtD
Primidone—Anorexia—Mitoxantrone—prostate cancer	0.000186	0.00153	CcSEcCtD
Primidone—Diplopia—Epirubicin—prostate cancer	0.000185	0.00152	CcSEcCtD
Primidone—CYP2C9—urine—prostate cancer	0.000184	0.12	CbGeAlD
Primidone—Anaemia—Etoposide—prostate cancer	0.000184	0.00151	CcSEcCtD
Primidone—Visual impairment—Docetaxel—prostate cancer	0.000183	0.0015	CcSEcCtD
Primidone—Decreased appetite—Estradiol—prostate cancer	0.000182	0.00149	CcSEcCtD
Primidone—Depression—Prednisone—prostate cancer	0.000182	0.00149	CcSEcCtD
Primidone—Gastrointestinal disorder—Estradiol—prostate cancer	0.000181	0.00148	CcSEcCtD
Primidone—Connective tissue disorder—Capecitabine—prostate cancer	0.000181	0.00148	CcSEcCtD
Primidone—Fatigue—Estradiol—prostate cancer	0.000181	0.00148	CcSEcCtD
Primidone—Vertigo—Etoposide—prostate cancer	0.000179	0.00147	CcSEcCtD
Primidone—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000178	0.00146	CcSEcCtD
Primidone—Eye disorder—Docetaxel—prostate cancer	0.000178	0.00146	CcSEcCtD
Primidone—Visual impairment—Capecitabine—prostate cancer	0.000177	0.00145	CcSEcCtD
Primidone—Dizziness—Goserelin—prostate cancer	0.000175	0.00143	CcSEcCtD
Primidone—Ataxia—Epirubicin—prostate cancer	0.000174	0.00143	CcSEcCtD
Primidone—Somnolence—Mitoxantrone—prostate cancer	0.000174	0.00142	CcSEcCtD
Primidone—Dizziness—Conjugated Estrogens—prostate cancer	0.000173	0.00142	CcSEcCtD
Primidone—Eye disorder—Capecitabine—prostate cancer	0.000172	0.00141	CcSEcCtD
Primidone—Diplopia—Doxorubicin—prostate cancer	0.000171	0.00141	CcSEcCtD
Primidone—Decreased appetite—Mitoxantrone—prostate cancer	0.00017	0.00139	CcSEcCtD
Primidone—Fatigue—Mitoxantrone—prostate cancer	0.000168	0.00138	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000168	0.00138	CcSEcCtD
Primidone—Vomiting—Goserelin—prostate cancer	0.000168	0.00138	CcSEcCtD
Primidone—Rash—Goserelin—prostate cancer	0.000167	0.00137	CcSEcCtD
Primidone—Dermatitis—Goserelin—prostate cancer	0.000167	0.00137	CcSEcCtD
Primidone—Vomiting—Conjugated Estrogens—prostate cancer	0.000167	0.00136	CcSEcCtD
Primidone—Mental disorder—Docetaxel—prostate cancer	0.000166	0.00136	CcSEcCtD
Primidone—Headache—Goserelin—prostate cancer	0.000166	0.00136	CcSEcCtD
Primidone—Malnutrition—Docetaxel—prostate cancer	0.000165	0.00136	CcSEcCtD
Primidone—Rash—Conjugated Estrogens—prostate cancer	0.000165	0.00135	CcSEcCtD
Primidone—Dermatitis—Conjugated Estrogens—prostate cancer	0.000165	0.00135	CcSEcCtD
Primidone—Headache—Conjugated Estrogens—prostate cancer	0.000164	0.00134	CcSEcCtD
Primidone—Ataxia—Doxorubicin—prostate cancer	0.000161	0.00132	CcSEcCtD
Primidone—Mental disorder—Capecitabine—prostate cancer	0.000161	0.00132	CcSEcCtD
Primidone—Connective tissue disorder—Prednisone—prostate cancer	0.000161	0.00132	CcSEcCtD
Primidone—Malnutrition—Capecitabine—prostate cancer	0.00016	0.00131	CcSEcCtD
Primidone—Skin disorder—Etoposide—prostate cancer	0.000158	0.00129	CcSEcCtD
Primidone—Nausea—Goserelin—prostate cancer	0.000157	0.00129	CcSEcCtD
Primidone—Nausea—Conjugated Estrogens—prostate cancer	0.000156	0.00127	CcSEcCtD
Primidone—Anorexia—Etoposide—prostate cancer	0.000155	0.00127	CcSEcCtD
Primidone—Eye disorder—Prednisone—prostate cancer	0.000153	0.00126	CcSEcCtD
Primidone—Anaemia—Docetaxel—prostate cancer	0.000153	0.00125	CcSEcCtD
Primidone—Asthenia—Estradiol—prostate cancer	0.00015	0.00123	CcSEcCtD
Primidone—Phenytoin—CYP2C19—prostate cancer	0.000149	0.0434	CrCbGaD
Primidone—Anaemia—Capecitabine—prostate cancer	0.000148	0.00121	CcSEcCtD
Primidone—Somnolence—Etoposide—prostate cancer	0.000144	0.00118	CcSEcCtD
Primidone—Phenobarbital—CYP2E1—prostate cancer	0.000144	0.042	CrCbGaD
Primidone—Vertigo—Capecitabine—prostate cancer	0.000144	0.00118	CcSEcCtD
Primidone—Mental disorder—Prednisone—prostate cancer	0.000144	0.00118	CcSEcCtD
Primidone—Drowsiness—Epirubicin—prostate cancer	0.000143	0.00117	CcSEcCtD
Primidone—Malnutrition—Prednisone—prostate cancer	0.000143	0.00117	CcSEcCtD
Primidone—Phenobarbital—CYP2C19—prostate cancer	0.000143	0.0416	CrCbGaD
Primidone—Phenobarbital—CYP1A1—prostate cancer	0.000142	0.0414	CrCbGaD
Primidone—Decreased appetite—Etoposide—prostate cancer	0.000141	0.00116	CcSEcCtD
Primidone—Arthralgia—Docetaxel—prostate cancer	0.000141	0.00115	CcSEcCtD
Primidone—CYP3A4—urine—prostate cancer	0.000141	0.0915	CbGeAlD
Primidone—Gastrointestinal disorder—Etoposide—prostate cancer	0.00014	0.00115	CcSEcCtD
Primidone—Asthenia—Mitoxantrone—prostate cancer	0.00014	0.00115	CcSEcCtD
Primidone—Fatigue—Etoposide—prostate cancer	0.00014	0.00115	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.00014	0.00115	CcSEcCtD
Primidone—Dizziness—Estradiol—prostate cancer	0.000139	0.00114	CcSEcCtD
Primidone—Arthralgia—Capecitabine—prostate cancer	0.000136	0.00112	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000135	0.00111	CcSEcCtD
Primidone—Vomiting—Estradiol—prostate cancer	0.000133	0.00109	CcSEcCtD
Primidone—Agranulocytosis—Epirubicin—prostate cancer	0.000133	0.00109	CcSEcCtD
Primidone—Nervous system disorder—Docetaxel—prostate cancer	0.000132	0.00109	CcSEcCtD
Primidone—Rash—Estradiol—prostate cancer	0.000132	0.00108	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—prostate cancer	0.000132	0.00108	CcSEcCtD
Primidone—Dermatitis—Estradiol—prostate cancer	0.000132	0.00108	CcSEcCtD
Primidone—Anaemia—Prednisone—prostate cancer	0.000132	0.00108	CcSEcCtD
Primidone—Headache—Estradiol—prostate cancer	0.000131	0.00108	CcSEcCtD
Primidone—Skin disorder—Docetaxel—prostate cancer	0.000131	0.00107	CcSEcCtD
Primidone—Anorexia—Docetaxel—prostate cancer	0.000129	0.00105	CcSEcCtD
Primidone—Nervous system disorder—Capecitabine—prostate cancer	0.000128	0.00105	CcSEcCtD
Primidone—Vertigo—Prednisone—prostate cancer	0.000128	0.00105	CcSEcCtD
Primidone—Skin disorder—Capecitabine—prostate cancer	0.000127	0.00104	CcSEcCtD
Primidone—Connective tissue disorder—Epirubicin—prostate cancer	0.000126	0.00103	CcSEcCtD
Primidone—Anorexia—Capecitabine—prostate cancer	0.000125	0.00102	CcSEcCtD
Primidone—Nausea—Estradiol—prostate cancer	0.000124	0.00102	CcSEcCtD
Primidone—Vomiting—Mitoxantrone—prostate cancer	0.000124	0.00102	CcSEcCtD
Primidone—Visual impairment—Epirubicin—prostate cancer	0.000124	0.00101	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—prostate cancer	0.000123	0.00101	CcSEcCtD
Primidone—Rash—Mitoxantrone—prostate cancer	0.000123	0.00101	CcSEcCtD
Primidone—Dermatitis—Mitoxantrone—prostate cancer	0.000123	0.00101	CcSEcCtD
Primidone—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000123	0.00101	CcSEcCtD
Primidone—Headache—Mitoxantrone—prostate cancer	0.000122	0.001	CcSEcCtD
Primidone—Arthralgia—Prednisone—prostate cancer	0.000121	0.000995	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000121	0.000989	CcSEcCtD
Primidone—Somnolence—Docetaxel—prostate cancer	0.00012	0.000984	CcSEcCtD
Primidone—Eye disorder—Epirubicin—prostate cancer	0.00012	0.000982	CcSEcCtD
Primidone—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000119	0.000976	CcSEcCtD
Primidone—Decreased appetite—Docetaxel—prostate cancer	0.000117	0.000962	CcSEcCtD
Primidone—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000117	0.000955	CcSEcCtD
Primidone—Asthenia—Etoposide—prostate cancer	0.000117	0.000955	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—prostate cancer	0.000117	0.000955	CcSEcCtD
Primidone—Fatigue—Docetaxel—prostate cancer	0.000116	0.000954	CcSEcCtD
Primidone—Nausea—Mitoxantrone—prostate cancer	0.000116	0.000951	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—prostate cancer	0.000114	0.000937	CcSEcCtD
Primidone—Nervous system disorder—Prednisone—prostate cancer	0.000114	0.000936	CcSEcCtD
Primidone—Decreased appetite—Capecitabine—prostate cancer	0.000114	0.000931	CcSEcCtD
Primidone—Skin disorder—Prednisone—prostate cancer	0.000113	0.000927	CcSEcCtD
Primidone—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000113	0.000925	CcSEcCtD
Primidone—Fatigue—Capecitabine—prostate cancer	0.000113	0.000924	CcSEcCtD
Primidone—Mental disorder—Epirubicin—prostate cancer	0.000112	0.00092	CcSEcCtD
Primidone—Malnutrition—Epirubicin—prostate cancer	0.000112	0.000914	CcSEcCtD
Primidone—Anorexia—Prednisone—prostate cancer	0.000111	0.00091	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—prostate cancer	0.000111	0.000908	CcSEcCtD
Primidone—Dizziness—Etoposide—prostate cancer	0.000107	0.00088	CcSEcCtD
Primidone—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000106	0.000869	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—prostate cancer	0.000104	0.000852	CcSEcCtD
Primidone—Vomiting—Etoposide—prostate cancer	0.000103	0.000847	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—prostate cancer	0.000103	0.000846	CcSEcCtD
Primidone—Anaemia—Epirubicin—prostate cancer	0.000103	0.000845	CcSEcCtD
Primidone—Rash—Etoposide—prostate cancer	0.000102	0.00084	CcSEcCtD
Primidone—Dermatitis—Etoposide—prostate cancer	0.000102	0.000839	CcSEcCtD
Primidone—Headache—Etoposide—prostate cancer	0.000102	0.000834	CcSEcCtD
Primidone—Decreased appetite—Prednisone—prostate cancer	0.000101	0.00083	CcSEcCtD
Primidone—Fatigue—Prednisone—prostate cancer	0.0001	0.000823	CcSEcCtD
Primidone—Vertigo—Epirubicin—prostate cancer	0.0001	0.000822	CcSEcCtD
Primidone—Asthenia—Docetaxel—prostate cancer	9.69e-05	0.000794	CcSEcCtD
Primidone—Nausea—Etoposide—prostate cancer	9.65e-05	0.000791	CcSEcCtD
Primidone—Anaemia—Doxorubicin—prostate cancer	9.54e-05	0.000782	CcSEcCtD
Primidone—Arthralgia—Epirubicin—prostate cancer	9.5e-05	0.000779	CcSEcCtD
Primidone—Phenytoin—CYP3A4—prostate cancer	9.46e-05	0.0276	CrCbGaD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	9.43e-05	0.000773	CcSEcCtD
Primidone—Asthenia—Capecitabine—prostate cancer	9.38e-05	0.000769	CcSEcCtD
Primidone—Vertigo—Doxorubicin—prostate cancer	9.28e-05	0.00076	CcSEcCtD
Primidone—Phenobarbital—CYP3A4—prostate cancer	9.07e-05	0.0264	CrCbGaD
Primidone—CHRNA7—renal system—prostate cancer	9.05e-05	0.0589	CbGeAlD
Primidone—Nervous system disorder—Epirubicin—prostate cancer	8.93e-05	0.000732	CcSEcCtD
Primidone—Dizziness—Docetaxel—prostate cancer	8.93e-05	0.000732	CcSEcCtD
Primidone—Skin disorder—Epirubicin—prostate cancer	8.84e-05	0.000725	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—prostate cancer	8.79e-05	0.00072	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.73e-05	0.000715	CcSEcCtD
Primidone—Anorexia—Epirubicin—prostate cancer	8.68e-05	0.000711	CcSEcCtD
Primidone—Dizziness—Capecitabine—prostate cancer	8.64e-05	0.000708	CcSEcCtD
Primidone—Vomiting—Docetaxel—prostate cancer	8.58e-05	0.000704	CcSEcCtD
Primidone—Rash—Docetaxel—prostate cancer	8.51e-05	0.000698	CcSEcCtD
Primidone—Dermatitis—Docetaxel—prostate cancer	8.5e-05	0.000697	CcSEcCtD
Primidone—Headache—Docetaxel—prostate cancer	8.46e-05	0.000693	CcSEcCtD
Primidone—Asthenia—Prednisone—prostate cancer	8.35e-05	0.000685	CcSEcCtD
Primidone—Vomiting—Capecitabine—prostate cancer	8.31e-05	0.000681	CcSEcCtD
Primidone—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.3e-05	0.00068	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—prostate cancer	8.26e-05	0.000677	CcSEcCtD
Primidone—Rash—Capecitabine—prostate cancer	8.24e-05	0.000675	CcSEcCtD
Primidone—Dermatitis—Capecitabine—prostate cancer	8.23e-05	0.000675	CcSEcCtD
Primidone—Headache—Capecitabine—prostate cancer	8.19e-05	0.000671	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—prostate cancer	8.18e-05	0.000671	CcSEcCtD
Primidone—Somnolence—Epirubicin—prostate cancer	8.1e-05	0.000664	CcSEcCtD
Primidone—Anorexia—Doxorubicin—prostate cancer	8.03e-05	0.000658	CcSEcCtD
Primidone—Nausea—Docetaxel—prostate cancer	8.02e-05	0.000657	CcSEcCtD
Primidone—GRIA2—testis—prostate cancer	7.95e-05	0.0517	CbGeAlD
Primidone—Decreased appetite—Epirubicin—prostate cancer	7.92e-05	0.000649	CcSEcCtD
Primidone—Gastrointestinal disorder—Epirubicin—prostate cancer	7.86e-05	0.000644	CcSEcCtD
Primidone—Fatigue—Epirubicin—prostate cancer	7.85e-05	0.000643	CcSEcCtD
Primidone—Nausea—Capecitabine—prostate cancer	7.76e-05	0.000636	CcSEcCtD
Primidone—Dizziness—Prednisone—prostate cancer	7.7e-05	0.000631	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.68e-05	0.000629	CcSEcCtD
Primidone—Somnolence—Doxorubicin—prostate cancer	7.49e-05	0.000614	CcSEcCtD
Primidone—GABRA5—testis—prostate cancer	7.45e-05	0.0485	CbGeAlD
Primidone—Vomiting—Prednisone—prostate cancer	7.4e-05	0.000607	CcSEcCtD
Primidone—Rash—Prednisone—prostate cancer	7.34e-05	0.000602	CcSEcCtD
Primidone—Dermatitis—Prednisone—prostate cancer	7.33e-05	0.000601	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—prostate cancer	7.32e-05	0.0006	CcSEcCtD
Primidone—Headache—Prednisone—prostate cancer	7.29e-05	0.000598	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.27e-05	0.000596	CcSEcCtD
Primidone—Fatigue—Doxorubicin—prostate cancer	7.26e-05	0.000595	CcSEcCtD
Primidone—CHRFAM7A—testis—prostate cancer	7.24e-05	0.0471	CbGeAlD
Primidone—GABRA3—testis—prostate cancer	6.94e-05	0.0451	CbGeAlD
Primidone—Nausea—Prednisone—prostate cancer	6.92e-05	0.000567	CcSEcCtD
Primidone—Asthenia—Epirubicin—prostate cancer	6.53e-05	0.000535	CcSEcCtD
Primidone—Asthenia—Doxorubicin—prostate cancer	6.05e-05	0.000495	CcSEcCtD
Primidone—Dizziness—Epirubicin—prostate cancer	6.02e-05	0.000494	CcSEcCtD
Primidone—CHRNA7—testis—prostate cancer	5.85e-05	0.0381	CbGeAlD
Primidone—Vomiting—Epirubicin—prostate cancer	5.79e-05	0.000475	CcSEcCtD
Primidone—Rash—Epirubicin—prostate cancer	5.74e-05	0.000471	CcSEcCtD
Primidone—Dermatitis—Epirubicin—prostate cancer	5.74e-05	0.00047	CcSEcCtD
Primidone—Headache—Epirubicin—prostate cancer	5.7e-05	0.000468	CcSEcCtD
Primidone—GABRB2—testis—prostate cancer	5.65e-05	0.0368	CbGeAlD
Primidone—Dizziness—Doxorubicin—prostate cancer	5.57e-05	0.000457	CcSEcCtD
Primidone—Nausea—Epirubicin—prostate cancer	5.41e-05	0.000443	CcSEcCtD
Primidone—Vomiting—Doxorubicin—prostate cancer	5.36e-05	0.000439	CcSEcCtD
Primidone—Rash—Doxorubicin—prostate cancer	5.31e-05	0.000435	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—prostate cancer	5.31e-05	0.000435	CcSEcCtD
Primidone—Headache—Doxorubicin—prostate cancer	5.28e-05	0.000433	CcSEcCtD
Primidone—CYP2C8—renal system—prostate cancer	5.08e-05	0.033	CbGeAlD
Primidone—Nausea—Doxorubicin—prostate cancer	5e-05	0.00041	CcSEcCtD
Primidone—CYP1A2—renal system—prostate cancer	4.75e-05	0.0309	CbGeAlD
Primidone—CYP2B6—renal system—prostate cancer	4.55e-05	0.0296	CbGeAlD
Primidone—GABRA2—lymph node—prostate cancer	3.74e-05	0.0244	CbGeAlD
Primidone—CYP3A4—renal system—prostate cancer	3.44e-05	0.0224	CbGeAlD
Primidone—CYP2C8—testis—prostate cancer	3.28e-05	0.0214	CbGeAlD
Primidone—CYP2B6—testis—prostate cancer	2.94e-05	0.0192	CbGeAlD
Primidone—CYP2C9—Metabolism—ACHE—prostate cancer	3.7e-06	3.31e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.7e-06	3.31e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.69e-06	3.3e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.69e-06	3.3e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.67e-06	3.28e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ITPR1—prostate cancer	3.67e-06	3.28e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NCOA2—prostate cancer	3.66e-06	3.28e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.66e-06	3.27e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.65e-06	3.26e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.64e-06	3.25e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.63e-06	3.24e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—MED12—prostate cancer	3.58e-06	3.2e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.56e-06	3.18e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GNG5—prostate cancer	3.55e-06	3.17e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PRKACB—prostate cancer	3.54e-06	3.17e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.53e-06	3.16e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.53e-06	3.16e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GGT1—prostate cancer	3.51e-06	3.14e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.51e-06	3.13e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.49e-06	3.12e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TYMS—prostate cancer	3.46e-06	3.1e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NCOA1—prostate cancer	3.46e-06	3.09e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.46e-06	3.09e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTM1—prostate cancer	3.42e-06	3.06e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NCOA3—prostate cancer	3.42e-06	3.06e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.41e-06	3.05e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.41e-06	3.05e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.39e-06	3.03e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.39e-06	3.03e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NQO1—prostate cancer	3.37e-06	3.02e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.36e-06	3e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—LPL—prostate cancer	3.36e-06	3e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NCOA2—prostate cancer	3.34e-06	2.99e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TH—prostate cancer	3.33e-06	2.97e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.3e-06	2.95e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTA2—prostate cancer	3.3e-06	2.95e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—RXRA—prostate cancer	3.29e-06	2.94e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.27e-06	2.93e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—HPGDS—prostate cancer	3.26e-06	2.92e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ABCG5—prostate cancer	3.26e-06	2.92e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.26e-06	2.92e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.25e-06	2.9e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.24e-06	2.9e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.24e-06	2.89e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ERCC2—prostate cancer	3.22e-06	2.88e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.2e-06	2.86e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.19e-06	2.85e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTA1—prostate cancer	3.19e-06	2.85e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—COMT—prostate cancer	3.17e-06	2.83e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ACHE—prostate cancer	3.16e-06	2.83e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTT1—prostate cancer	3.16e-06	2.83e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTP1—prostate cancer	3.15e-06	2.82e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NAT2—prostate cancer	3.15e-06	2.82e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.15e-06	2.82e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTO1—prostate cancer	3.15e-06	2.82e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GGT1—prostate cancer	3.13e-06	2.8e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.13e-06	2.8e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.12e-06	2.79e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.11e-06	2.78e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ITPR1—prostate cancer	3.1e-06	2.77e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NCOA1—prostate cancer	3.09e-06	2.76e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NQO1—prostate cancer	3.08e-06	2.75e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.05e-06	2.73e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.04e-06	2.72e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.04e-06	2.72e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TH—prostate cancer	3.03e-06	2.71e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PRKACB—prostate cancer	3.03e-06	2.71e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—MTHFR—prostate cancer	3.03e-06	2.7e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—LRP2—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PLCB2—prostate cancer	3.02e-06	2.7e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.01e-06	2.69e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP3A4—prostate cancer	3e-06	2.68e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP17A1—prostate cancer	3e-06	2.68e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.99e-06	2.67e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PPARA—prostate cancer	2.97e-06	2.65e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—P4HB—prostate cancer	2.96e-06	2.65e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.95e-06	2.64e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.95e-06	2.64e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—RXRA—prostate cancer	2.94e-06	2.63e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TYMS—prostate cancer	2.93e-06	2.62e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTM1—prostate cancer	2.9e-06	2.59e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.88e-06	2.58e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GGT1—prostate cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NCOA2—prostate cancer	2.85e-06	2.55e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—LPL—prostate cancer	2.84e-06	2.54e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—COMT—prostate cancer	2.83e-06	2.53e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTP1—prostate cancer	2.81e-06	2.52e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NCOA1—prostate cancer	2.81e-06	2.52e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.81e-06	2.51e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CAV1—prostate cancer	2.79e-06	2.49e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.77e-06	2.48e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ITPR1—prostate cancer	2.77e-06	2.48e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—MED12—prostate cancer	2.76e-06	2.47e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.75e-06	2.46e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GNG5—prostate cancer	2.74e-06	2.45e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ERCC2—prostate cancer	2.72e-06	2.44e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.72e-06	2.43e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.72e-06	2.43e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—RXRA—prostate cancer	2.68e-06	2.39e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.66e-06	2.38e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.64e-06	2.36e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NQO1—prostate cancer	2.63e-06	2.35e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TYMS—prostate cancer	2.62e-06	2.34e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.6e-06	2.33e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TH—prostate cancer	2.59e-06	2.32e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTM1—prostate cancer	2.59e-06	2.31e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—COMT—prostate cancer	2.58e-06	2.31e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.58e-06	2.3e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.57e-06	2.29e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.56e-06	2.29e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.56e-06	2.29e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.55e-06	2.28e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.54e-06	2.27e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—LPL—prostate cancer	2.54e-06	2.27e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.53e-06	2.26e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.52e-06	2.25e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.52e-06	2.25e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPARA—prostate cancer	2.51e-06	2.25e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.5e-06	2.24e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.48e-06	2.22e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.45e-06	2.19e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ACHE—prostate cancer	2.44e-06	2.18e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.44e-06	2.18e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GGT1—prostate cancer	2.44e-06	2.18e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ERCC2—prostate cancer	2.43e-06	2.17e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.41e-06	2.16e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—INS—prostate cancer	2.41e-06	2.15e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NCOA1—prostate cancer	2.41e-06	2.15e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TYMS—prostate cancer	2.39e-06	2.13e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.37e-06	2.12e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CAV1—prostate cancer	2.36e-06	2.11e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTM1—prostate cancer	2.36e-06	2.11e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CREBBP—prostate cancer	2.36e-06	2.11e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.35e-06	2.1e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.34e-06	2.09e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—LPL—prostate cancer	2.32e-06	2.07e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.31e-06	2.07e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—RXRA—prostate cancer	2.29e-06	2.05e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—MTHFR—prostate cancer	2.29e-06	2.04e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.26e-06	2.02e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPARA—prostate cancer	2.24e-06	2.01e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.24e-06	2e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.23e-06	2e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.23e-06	1.99e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ERCC2—prostate cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—COMT—prostate cancer	2.2e-06	1.97e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NCOA2—prostate cancer	2.2e-06	1.97e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTP1—prostate cancer	2.19e-06	1.96e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ITPR1—prostate cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.15e-06	1.92e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.12e-06	1.9e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NOS3—prostate cancer	2.11e-06	1.89e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CAV1—prostate cancer	2.11e-06	1.89e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.1e-06	1.88e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—MTHFR—prostate cancer	2.08e-06	1.86e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.05e-06	1.84e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPARA—prostate cancer	2.05e-06	1.83e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TYMS—prostate cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—INS—prostate cancer	2.04e-06	1.82e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NQO1—prostate cancer	2.03e-06	1.81e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTM1—prostate cancer	2.02e-06	1.8e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.01e-06	1.8e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TH—prostate cancer	2e-06	1.79e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CREBBP—prostate cancer	2e-06	1.78e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—LPL—prostate cancer	1.98e-06	1.77e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.95e-06	1.74e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.95e-06	1.74e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS2—prostate cancer	1.93e-06	1.73e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CAV1—prostate cancer	1.92e-06	1.72e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.92e-06	1.72e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.91e-06	1.71e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ERCC2—prostate cancer	1.9e-06	1.69e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.89e-06	1.69e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GGT1—prostate cancer	1.88e-06	1.68e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.86e-06	1.66e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.84e-06	1.64e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.64e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—INS—prostate cancer	1.82e-06	1.63e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NOS3—prostate cancer	1.79e-06	1.6e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—MTHFR—prostate cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CREBBP—prostate cancer	1.78e-06	1.59e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—RXRA—prostate cancer	1.77e-06	1.58e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.75e-06	1.57e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPARA—prostate cancer	1.75e-06	1.56e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—COMT—prostate cancer	1.7e-06	1.52e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.69e-06	1.51e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.69e-06	1.51e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTEN—prostate cancer	1.68e-06	1.5e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.67e-06	1.49e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—INS—prostate cancer	1.66e-06	1.48e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.65e-06	1.47e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CAV1—prostate cancer	1.64e-06	1.47e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.63e-06	1.46e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.62e-06	1.45e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—EP300—prostate cancer	1.61e-06	1.44e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NOS3—prostate cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TYMS—prostate cancer	1.57e-06	1.41e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.57e-06	1.4e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.56e-06	1.39e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.54e-06	1.38e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—LPL—prostate cancer	1.53e-06	1.37e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.5e-06	1.34e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.47e-06	1.32e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.46e-06	1.31e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS2—prostate cancer	1.46e-06	1.3e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NOS3—prostate cancer	1.45e-06	1.3e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTEN—prostate cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—INS—prostate cancer	1.42e-06	1.27e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CREBBP—prostate cancer	1.39e-06	1.24e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—EP300—prostate cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPARA—prostate cancer	1.35e-06	1.21e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.34e-06	1.2e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.32e-06	1.18e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTEN—prostate cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CAV1—prostate cancer	1.27e-06	1.13e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NOS3—prostate cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—EP300—prostate cancer	1.21e-06	1.08e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.06e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTEN—prostate cancer	1.16e-06	1.04e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.16e-06	1.03e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS2—prostate cancer	1.14e-06	1.02e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—EP300—prostate cancer	1.11e-06	9.89e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—INS—prostate cancer	1.09e-06	9.78e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CREBBP—prostate cancer	1.07e-06	9.57e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.02e-06	9.08e-06	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.01e-06	8.99e-06	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTEN—prostate cancer	9.91e-07	8.86e-06	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—AKT1—prostate cancer	9.7e-07	8.67e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NOS3—prostate cancer	9.59e-07	8.57e-06	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—EP300—prostate cancer	9.45e-07	8.45e-06	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.97e-07	8.02e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.85e-07	7.91e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS2—prostate cancer	8.77e-07	7.84e-06	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—AKT1—prostate cancer	8.21e-07	7.34e-06	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CA—prostate cancer	8.18e-07	7.31e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTEN—prostate cancer	7.65e-07	6.84e-06	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—AKT1—prostate cancer	7.33e-07	6.55e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—EP300—prostate cancer	7.29e-07	6.52e-06	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.99e-07	6.25e-06	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—AKT1—prostate cancer	6.68e-07	5.98e-06	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—AKT1—prostate cancer	5.71e-07	5.11e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.4e-07	4.82e-06	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—AKT1—prostate cancer	4.41e-07	3.94e-06	CbGpPWpGaD
